双歧杆菌三联活菌肠溶胶囊联合蒙脱石散治疗小儿腹泻的临床疗效观察

Observation on clinical efficacy of bifid triple viable capsules dissolving at intestines combined with montmorillonite powder in the treatment of diarrhea in children

目的 观察双歧杆菌三联活菌肠溶胶囊联合蒙脱石散治疗小儿腹泻的疗效。方法 50例腹泻患儿,随机分为观察组和对照组,各25例。对照组接受常规支持及蒙脱石散治疗,观察组在对照组治疗基础上联合双歧杆菌三联活菌肠溶胶囊治疗。比较两组患儿治疗效果及不良反应发生情况。结果 观察组治疗总有效率96.00%高于对照组的76.00%,差异有统计学意义(P<0.05)。观察组不良反应发生率为12.00%,对照组患儿不良反应发生率为16.00%,两组患儿不良反应发生率比较差异无统计学意义(P>0.05)。结论 联合使用双歧杆菌三联活菌肠溶胶囊和蒙脱石散治疗小儿腹泻,其效果明显,安全可靠,可以推广应用。

Objective To observe the efficacy of bifid triple viable capsules dissolving at intestines combined with montmorillonite powder in the treatment of diarrhea in children.Methods A total of 50 children with diarrhea were randomly divided into observation group and control group,with 25 cases in each group.The control group received routine support and montmorillonite powder treatment,and the observation group was treated with bifid triple viable capsules dissolving at intestines on the basis of the control group.The therapeutic effect and adverse reactions were compared between the two groups.Results The total effective rate of 96.00%in the observation group was higher than that of 76.00%in the control group,and the difference was statistically significant(P<0.05).The incidence of adverse reactions in the observation group was 12.00%,and that in the control group was 16.00%;there was no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion The combined use of bifid triple viable capsules dissolving at intestines and montmorillonite powder in the treatment of diarrhea in children is effective,safe and reliable,and can be widely used.